Articles about 'Chris Lowe'

Meet the young biotech entrepreneur with two companies to her name and a plan to revolutionise the way we manage our health.

Improvements in public health, education and medicine mean that our lives are much longer than at any point in human history. Thanks to studies of volunteers from the eastern region, we may be able to spend these extra years living independently and in good health.

Nanobots that patrol our bodies, killer immune cells hunting and destroying cancer cells, biological scissors that cut out defective genes: these are just some of technologies that Cambridge researchers are developing which are set to revolutionise medicine in the future.

How will precision medicine define 21st-century therapeutics? What will future healthcare look like? And what actually lies ‘beyond the pill’? Professor Chris Lowe, inaugural Director of the Cambridge Academy of Therapeutic Sciences, takes the long view on the future of therapeutics.

The Cambridge Academy of Therapeutic Sciences (CATS), a new initiative that aims to establish a world-leading platform for collaboration between academia and industry in the development of therapeutics, will be launched today by the Vice-Chancellor of the University of Cambridge.

Worried you might be at risk from diabetes? Check your phone: it might help stop you getting the disease. And if you already have diabetes? Your phone might even help you monitor your condition at home.

The Institute has been recognised for its initiative, innovation and originality.

The recently announced merger of the Department of Chemical Engineering and the Institute of Biotechnology heralds a new dimension for research and teaching opportunities in Cambridge.